123456789/14
- Quantification of allosteric communications in matrix metalloprotease-1 on alpha-synuclein aggregates and substratedependent virtual screening
- Quantifying the heterogeneity of cognitive functioning in Alzheimer’s disease to extend the placebo-treatment dichotomy: Latent class analysis of individual-participant data from five pivotal randomized clinical trials of donepezil
- Linking the Mini-Mental State Examination, the Alzheimer’s Disease Assessment Scale–Cognitive Subscale and the Severe Impairment Battery: evidence from individual participant data from five randomised clinical trials of donepezil
- Care needs of people with dementia in the peri-operative environment: A systematic review
- Ethics of Early Intervention in Alzheimer’s Disease
- Health Outcome Prioritization in Alzheimer’s Disease: Understanding the Ethical Landscape.
- Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease A Randomized Clinical Trial
- APOE genotype and cognition in healthy individuals at risk of Alzheimer’s disease: A review
- CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice
- Can dietary supplements maintain cognition in mid- to late-life?